Fluxion Biosciences is a biotechnology company that designs, manufactures, and sells innovative microfluidic systems for cellular analysis. Their platforms, including the IsoFlux, BioFlux, and IonFlux systems, are utilized by researchers in academia, biotechnology, and pharmaceutical companies. These tools enable applications such as circulating tumor cell (CTC) analysis for cancer research, drug discovery (e.g., screening ion channel targets), biofilm analysis, and live-cell assays under physiological flow conditions. Fluxion aims to provide researchers with more precise, efficient, and automated tools to accelerate biological research and therapeutic development.
The Brisbane headquarters serves as the central hub for research and development, product manufacturing, global sales and marketing, customer support, and corporate administration.
The facility likely includes specialized laboratories for microfluidics research, device engineering, and biological application development, potentially with cleanroom capabilities for manufacturing their proprietary microfluidic chips.
The work culture is expected to be innovative, science-driven, and collaborative, fostering an environment where cutting-edge research translates into practical tools for the life sciences community. Emphasis is likely placed on precision, quality, and customer-focused solutions.
Its location in the Bay Area provides access to a rich ecosystem of academic research institutions, other biotech companies, a skilled talent pool, and venture capital, fostering innovation and partnerships.
Fluxion Biosciences maintains a global presence primarily through its headquarters in California, USA, and an extensive network of certified distributors and partners across North America, Europe, Asia, and other international markets. These partners provide sales, application support, and technical service for Fluxion's portfolio of cellular analysis systems, ensuring researchers worldwide can access and effectively utilize their technologies.
150 North Hill Drive, Suite 24
Brisbane
CA
USA
Address: N/A - Operates through a network of international distributors
To extend market penetration, provide localized customer support, and facilitate product accessibility for researchers across Europe, Asia-Pacific, and other key international territories.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Fluxion Biosciences' leadership includes:
Fluxion Biosciences has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major executive new hires or departures announced by Fluxion Biosciences in the last 12 months, suggesting stability within the current leadership team.
Discover the tools Fluxion Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Fluxion Biosciences likely utilizes common corporate email formats. The most probable format combines the first initial and last name of the employee, followed by the company's domain.
[firstinitial][lastname]@fluxionbio.com
Format
jjensen@fluxionbio.com
Example
80%
Success rate
PR Newswire • April 18, 2023
Fluxion Biosciences announced a publication detailing how its IsoFlux System was used to analyze circulating tumor cells (CTCs) for monitoring treatment efficacy in metastatic breast cancer patients, offering potential for personalized medicine....more
Fluxion Biosciences Website (News/Events) • February 7, 2023
Fluxion Biosciences announced its participation in the SLAS2023 International Conference and Exhibition, where it planned to present its latest microfluidic technologies for advanced cell-based assays, including live cell imaging and automated screening....more
GlobeNewswire • October 27, 2020
A study conducted by the National Cancer Institute (NCI) utilized Fluxion Biosciences' IsoFlux system for the isolation and analysis of circulating tumor cells in small cell lung cancer patients, highlighting its application in oncology research and liquid biopsies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Fluxion Biosciences, are just a search away.